Wilson Sonsini advised Aquaron Acquisition Corp. on the deal. Bestpath (Shanghai) IoT Technology Co., Ltd. (Bestpath), a pioneering hydrogen fuel cell powered vehicle company in China,...
Aquaron Acquisition Corp.’s Merger with Bestpath
Finanty’s US$8 Million Corporate Bond Issue
Osorio Asociados and Rebaza Alcázar & De Las Casas has represented Finanty in the transaction. Finanty executed the issuance of its First Corporate Bond Programme, placed for...
Diebold Nixdorf’s $55 Million FILO Asset-Based Financing
Davis Polk advised a group of lenders to Diebold Nixdorf on the transaction. Diebold Nixdorf, Incorporated announced an amendment to its asset-based credit agreement providing for...
Mastercard’s Acquisition of Baffin Bay Networks
Wilson Sonsini advised Mastercard on the deal. Mastercard announced it acquired cloud-based cybersecurity company Baffin Bay Networks, which offers the latest in AI technology to automatically...
Alimera Sciences’ $27 Million Investment
Olshan Frome Wolosky represented Velan Capital in the transaction. Velan Capital co-led an investment in a $12 million PIPE consisting of Series B preferred stock and...
Japan Industrial Partners’ ¥2 Trillion Acquisition of Toshiba
Davis Polk is advising Japan Industrial Partners on North and South American aspects, including advice concerning U.S. securities law and regulatory approvals, of the deal. Japan...
Droplet’s €8 Million Seed Investment
Wilson Sonsini advised Droplet Biosciences on the deal. Droplet Biosciences announced an $8 million seed investment to establish proof of concept for the company’s lymph diagnostic...
Blue Flame Medical v. Chain Bridge Bank
Kramer Levin represented Chain Bridge in the case. On March 20, 2023, a panel of the U.S. Court of Appeals for the Fourth Circuit in Richmond,...
Southwest Gas’ $300 Million Senior Notes Offering
Morrison & Foerster advised Southwest Gas on the offering, and Davis Polk advised the representatives of the several underwriters. Southwest Gas Corporation announced an SEC-registered offering...
EpiBiologics’ $50 Million Series A Financing
Wilson Sonsini advised EpiBiologics on the deal. EpiBiologics, a biotechnology company building a next-generation antibody-based protein degradation platform for membrane and extracellular drug targets, launched with...